Screener
Bicara Therapeutics BCAX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 346 | 330 |
| Right of use asset – operating lease | 1,428 | 1,701 |
| Other assets | 6,910 | 6,910 |
| Total assets | $553,599 | $430,994 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $6,188 | $5,515 |
| Accounts payable – related party | 1,252 | 2,278 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bicara Therapeutics's total assets?
- Bicara Therapeutics (BCAX) reported total assets of $553.6M in Q1 2026.
- How has Bicara Therapeutics's total assets changed year-over-year?
- Bicara Therapeutics's total assets increased by 15.8% year-over-year, from $478.08M to $553.6M.
- What is the long-term trend for Bicara Therapeutics's total assets?
- Over 2 years (2023 to 2025), Bicara Therapeutics's total assets has grown at a 35.7% compound annual growth rate (CAGR), from $233.98M to $430.99M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Bicara Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude